{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-035950","form_type":"8-K","ticker":"XAGE","cik":"0001842939","company_name":"Longevity Health Holdings, Inc.","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.237710+00:00","generated_at":"2026-05-25T02:05:08.619102+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Carmell rebrands to Longevity Health (XAGE); guides FY25 rev $3-4M; names Vice Chairman","bullets":["Name change to Longevity Health Holdings effective March 5; tickers to XAGE/XAGEW March 10.","Patrick Sturgeon appointed Vice Chairman; previously CFO and board director since July 2023.","Combined sales grew 34% in Jan-Feb 2025 vs 2024 post Elevai acquisition.","Elevai's post-acquisition burn rate reduced >50% via overhead cost synergies.","FY25 revenue guidance $3-4M; Q2 2025 product launches include hair growth serum, soapless facial cleanser, etc."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-035950","json":"https://secwatch.observer/filing/0000950170-25-035950.json","markdown":"https://secwatch.observer/filing/0000950170-25-035950.md","text":"https://secwatch.observer/filing/0000950170-25-035950.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842939/000095017025035950/0000950170-25-035950-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842939/000095017025035950/ctcx-20250305.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T02:05:08.619102+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}